May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Angiopoietin 2 (Ang2) Increases or Decreases Neovascularization (NV) Depending Upon the Setting
Y. Oshima; S. Oshima; K. Takahashi; H. Nambu; R.S. Apte; E. Duh; S.F. Hackett; D.J. Zack; P.A. Campochiaro
Author Affiliations & Notes
  • Y. Oshima
    Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • S. Oshima
    Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • K. Takahashi
    Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • H. Nambu
    Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • R.S. Apte
    Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • E. Duh
    Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • S.F. Hackett
    Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • D.J. Zack
    Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • P.A. Campochiaro
    Ophthalmology, Wilmer Eye Institute, Baltimore, MD, United States
  • Footnotes
    Commercial Relationships  Y. Oshima, None; S. Oshima, None; K. Takahashi, None; H. Nambu, None; R.S. Apte, None; E. Duh, None; S.F. Hackett, None; D.J. Zack, None; P.A. Campochiaro, None.
  • Footnotes
    Support  NIH Grant EY05951, EY12609
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4519. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Angiopoietin 2 (Ang2) Increases or Decreases Neovascularization (NV) Depending Upon the Setting
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Y. Oshima, S. Oshima, K. Takahashi, H. Nambu, R.S. Apte, E. Duh, S.F. Hackett, D.J. Zack, P.A. Campochiaro; Angiopoietin 2 (Ang2) Increases or Decreases Neovascularization (NV) Depending Upon the Setting . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4519.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: To investigate the role of ang2 in the retina. Methods: Five independent lines of tetracycline response element (TRE)/murine ang2 (TRE/ang2) transgenic mice were generated. These mice were crossed with reverse tetracycline transactivator (rtTA)/rhodopsin promoter (rtTA/rho) or rtTA/CMV promoter (rtTA/CMV) mice to generate double transgenics. Expression of ang2 was evaluated by RT-PCR and immunohistochemistry. Mice with doxycycline (dox)-inducible ubiquitous expression of ang2 (rtTA/CMV-TRE/ang2) or dox-inducible expression of ang2 in the retina (rtTA/rho-TRE/ang2) were used to investigate the effect of increased expression of ang2 on retinal vascular development, ischemic retinopathy, VEGF-induced subretinal NV, and choroidal NV (CNV). Results: Mothers of newborn rtTA/CMV-TRE/ang2 mice were given drinking water supplemented with doxycycline (dox) and pups were given subcutaneous injections of dox from P8-P10. At P11, compared to untreated double transgenics, dox-treated mice showed increased expression of ang2 in the retina and accelerated development of the deep capillary bed. Although this physiologic angiogenesis was accelerated, it did not overshoot and by P18 the difference between dox-treated and untreated mice disappeared. Compared to untreated rtTA/CMV-TRE/ang2 mice with oxygen-induced ischemic retinopathy, those treated with dox had significantly more retinal NV. Adult rtTA/rho-TRE/ang2 mice that also carried a rho/VEGF transgene had subretinal NV typical of rho/VEGF mice when untreated, but the NV regressed when ang2 expression was induced by dox treatment. Likewise, when adult rtTA/rho-TRE/ang2 mice with CNV at Bruch’s membrane rupture sites were treated with dox, the CNV regressed. Conclusions: Increased expression of ang2 in hypoxic retina enhances retinal NV, but in normoxic eyes ang2 causes regression of subretinal or choroidal NV.

Keywords: neovascularization • transgenics/knock-outs • retina 
© 2003, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept